CIK 0001724521 · Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473898435
- Phone
- (510) 694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- 4 Planned sale Chief Operating Officer sold 50,292 shares at an average $14.92 ($750,412)
- 4 Planned sale Chief Accounting Officer sold 2,831 shares at $13.00 ($36,803)
- 4 Planned sale Chief Accounting Officer sold 1,579 shares at $11.88 ($18,758)
- 4 Grant or award Director acquired 13,300 shares (grant or award)
- 4 Grant or award Director acquired 13,300 shares (grant or award)
- 4 Grant or award Director acquired 13,300 shares (grant or award)
- 4 Grant or award Director acquired 13,300 shares (grant or award)
- 4 Grant or award Director acquired 13,300 shares (grant or award)
- 4 Grant or award Director acquired 13,300 shares (grant or award)
- 4 Grant or award Director acquired 13,300 shares (grant or award)
- 4 Open-market buy Director bought 20,000 shares at $10.06 ($201,200)
- 4 Open-market buy Chief Executive Officer bought 19,800 shares at $10.18 ($201,465)
- 4 Open-market buy 10% owner bought 1,363,636 shares at $11.00 ($14,999,996)
- 4 Grant or award Chief Medical Officer acquired 75,193 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award General Counsel acquired 37,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 165,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Operating Officer acquired 50,000 shares (grant or award)
Page 3 of 15 · 290 filings